VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $416,000 | -99.1% | 4,100 | -98.4% | 0.03% | -99.1% |
| Q3 2015 | $44,751,000 | -20.1% | 250,879 | -0.5% | 3.80% | -17.3% |
| Q2 2015 | $56,023,000 | +9.7% | 252,187 | -1.9% | 4.60% | +5.8% |
| Q1 2015 | $51,066,000 | +28.7% | 257,107 | -7.3% | 4.35% | +31.2% |
| Q4 2014 | $39,680,000 | +12.3% | 277,270 | +3.0% | 3.31% | +1.2% |
| Q3 2014 | $35,319,000 | +4.2% | 269,202 | +0.2% | 3.27% | +4.9% |
| Q2 2014 | $33,892,000 | -48.0% | 268,729 | -48.6% | 3.12% | -3.9% |
| Q1 2014 | $65,218,000 | +112.8% | 523,296 | +100.4% | 3.25% | +3.3% |
| Q4 2013 | $30,648,000 | +23.3% | 261,063 | +9.5% | 3.14% | +5.2% |
| Q3 2013 | $24,863,000 | +25.6% | 238,317 | +3.6% | 2.99% | +11.7% |
| Q2 2013 | $19,803,000 | – | 230,058 | – | 2.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |